← Back to headlines
New results "above expectations" - but the stock is falling
Reactions to Novo Nordisk's interim report are dragging down the entire Copenhagen stock exchange on Wednesday. However, pharmaceutical analyst Johan Unnerus believes the pharmaceutical giant is surprising positively. – They are clearly delivering…
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
